News Search Results
May 28, 2026, 21:02 ET HMS Vision Inc. and Wenzhou Medical University Announce the Expansion of Their Simulation-Based Training Center During Vision China 2026
Wenzhou Medical University, Zhongshan Ophthalmic Center at Sun Yat-sen University, and He Eye Specialist Hospital, HMS Vision supports innovation in ophthalmology and helps reduce preventable blindness across China. Beijing HMS Vision Technical Consulting Co. Ltd. deploys the HelpMeSee Simulation-based Eye
More news about: HMS Vision Inc.
May 28, 2026, 15:00 ET American Academy of Pediatric Dentistry Names New Board Officers and Trustees at Annual Meeting
children. His son is a dentist and physician, specializing in Oral and Maxillofacial Surgery. His oldest daughter is a physician specializing in ophthalmology, and his youngest daughter is a mental health counselor. Jacob K. LeePRESIDENT-ELECTDr. Jacob Lee earned
More news about: American Academy of Pediatric Dentistry
May 28, 2026, 12:28 ET Parker Waichman LLP Files Lawsuit on behalf of Florida Resident Alleging Development of Irreversible Eye Condition, NAION, after taking Ozempic and Mounjaro
concerns about the failure of drug manufacturers to warn consumers and medical professionals about these risks.A 2025 study published in JAMA Ophthalmology examined nine patients who developed optic nerve disorders after using GLP-1 medications, with the majority suffering from
More news about: Parker Waichman LLP
May 28, 2026, 10:35 ET Prevent Blindness Declares June as Cataract Month, Providing Educational Resources on the Leading Cause of Vision Loss in the United States
Cataract, Cornea, Anterior Segment Specialist with Virginia Eye Consultants and Assistant Professor at Eastern Virginia Medical School, Department of Ophthalmology.In the new June episode of the
More news about: Prevent Blindness
May 27, 2026, 07:02 ET ixlayer Appoints Helmut Osorio as General Manager to Accelerate Direct-to-Patient Growth for Biopharma
and that experience is exactly what our biopharma partners will benefit from."Osorio most recently served as Senior Director of Marketing, Ophthalmology at Regeneron Pharmaceuticals, where he led science-based marketing strategy and cross-functional launch execution for EYLEA HD. He previously advised
More news about: ixlayer
May 26, 2026, 14:25 ET Eyesafe Welcomes Blake Gaiser, Former Head of Smartphone Product Management at Samsung, as Strategic Advisor
a world-class team of eye doctors, engineers, and scientists with expertise in electronics, display materials, light management, optometry, and ophthalmology. The Eyesafe brand is trusted by millions of consumers and integrated into digital devices from Dell, HP, Lenovo, Samsung, LG, ZAGG, and more. Recognized
More news about: Eyesafe
May 26, 2026, 09:26 ET At the ASCO® 2026 Annual Meeting, Sun Pharma to Present Pivotal Long-Term Follow-up Data on UNLOXCYT™ (cosibelimab-ipdl)
company in the U.S. as well as Global Emerging Markets. Sun's high growth Innovative Medicines portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for about 20% of company sales. The company's vertically integrated operations deliver high-quality medicines,
More news about: Sun Pharma
May 26, 2026, 02:45 ET Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company
company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases
More news about: Astellas Pharma Inc.
May 23, 2026, 10:00 ET Meet Clicklinks: The Innovation Hub for Original Drug Discovery
on nine major therapeutic battlegrounds: oncology, metabolism, autoimmune diseases, neuroscience, cardiovascular diseases, infectious diseases, ophthalmology, aging, and companion animal health. Keeping R&D aligned with the world's most urgent clinical needs — without losing direction or following
More news about: Sanyou Bio
May 22, 2026, 11:14 ET Parker Waichman LLP Files Lawsuit on behalf of Florida Resident Alleging Development of Irreversible Eye Condition, NAION, after taking Ozempic
concerns about the failure of drug manufacturers to warn consumers and medical professionals about these risks.A 2025 study published in JAMA Ophthalmology examined nine patients who developed optic nerve disorders after using GLP-1 medications, with the majority suffering from
More news about: Parker Waichman LLP
May 22, 2026, 00:58 ET 2026 ASCO Abstract Highlights | Innovent Announces Preliminary PoC data of IBI363 (PD-1/IL-2α-bias bispecific fusion protein) in Combination with Chemotherapy as First-line Treatment for Advanced NSCLC, Showing Encouraging Efficacy Signals and Favorable Safety
that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, first announced the preliminary PoC clinical study results for its global first-in-class PD-1/IL-2α-bias bispecific
More news about: Innovent Biologics
May 21, 2026, 19:49 ET 2026 ASCO Abstract Highlights: Innovent Biologics' IBI363 (PD-1/IL-2α-bias bispecific fusion protein) Demonstrates Robust Survival Benefits in Long-Term Follow-up of PoC Study in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer
that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces updated data from the Phase 1 PoC clinical study of its first-in-class PD-1/IL-2α-bias bispecific
More news about: Innovent Biologics
May 21, 2026, 17:34 ET Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting
Pharmaceuticals, Inc.: Formosa Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to the development of high-impact therapeutics in ophthalmology and oncology. The company's first product, a novel corticosteroid formulation approved by US FDA (BYQLOVI™) and Health Canada (CLOBIVIS™), offers
More news about: Formosa Pharmaceuticals Inc.,
May 21, 2026, 11:02 ET Top Salt Lake City Oculofacial Plastic Surgeon Dr. Kian Eftekhari to Present at the 2026 Vegas Cosmetic Surgery & Aesthetic Dermatology Conference
founding the Eyelid Center of Utah, he served as Assistant Professor of Ophthalmology at the University of North Carolina at Chapel Hill in the Kittner Eye Center. Dr. Eftekhari is board-certified by the American Board of Ophthalmology and is an active member of the American Society of Ophthalmic Plastic
More news about: Eyelid Center of Utah
May 21, 2026, 09:15 ET Verana Health Delivers Powerful Update to RWD Bladder Cancer Database
artificial intelligence to unlock the true potential of real-world data. With exclusive access to the world's largest patient data sources in oncology, ophthalmology, neurology, and urology. Verana Health is powering real-world evidence generation. Clinicians utilize these insights to improve the quality of care
More news about: Verana Health
May 21, 2026, 07:30 ET HelpMeSee Accelerates MSICS Training in India with New Guwahati Cataract Learning Center to Build Immediate Surgical Capacity
training to this region. Training has always been a priority for SSDN, and this project will give further impetus to our mission, particularly for ophthalmology trainees from Assam and the Northeast," said Dr. Kasturi Bhattacharjee, Director, Clinical and Academics, SSDN.Another defining feature is
More news about: HelpMeSee
May 20, 2026, 23:30 ET HelpMeSee Accelerates MSICS Training in India with New Guwahati Cataract Learning Center to Build Immediate Surgical Capacity
training to this region. Training has always been a priority for SSDN, and this project will give further impetus to our mission, particularly for ophthalmology trainees from Assam and the Northeast," said Dr. Kasturi Bhattacharjee, Director, Clinical and Academics, SSDN.Another defining feature is
More news about: HelpMeSee
May 20, 2026, 09:50 ET Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets
Year Results from the Phase 1/2a Study," was presented by Eyal Banin, M.D., Ph.D., Center for Retinal and Macular Degenerations, Department of Ophthalmology Hadassah-Hebrew University Medical Center and Faculty of Medicine, on behalf of Roche and Genentech, a member of the Roche Group."We are
More news about: Market News Updates
May 20, 2026, 07:00 ET InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer
technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.Forward-Looking
More news about: InMode LTD
May 19, 2026, 12:00 ET Century Health Raises $5M Seed Round as AI-Powered Platform Achieves 97% Accuracy in Clinical Data Abstraction
Ventures. Strategic angel investors in the round include Zorba Lieberman, founder of Citeline, and clinicians across nephrology, neurology, and ophthalmology. The funding will be used to scale collaborations and use cases with pharmaceutical and life sciences partners, grow its specialty provider data
More news about: Century Health
May 19, 2026, 10:00 ET The First Dedicated Dry Eye Telehealth Brand Has Arrived: Rain Eyecare Launches FeelRain.com
EyeRain Eyecare isn't just selling eye drops — it's defining a new standard for personalized dry eye relief. By bridging the gap between clinical ophthalmology and direct-to-consumer convenience, Rain Eyecare helps customers move beyond temporary masking of symptoms toward long-term, doctor-reviewed relief
More news about: Rain Eyecare LLC
May 19, 2026, 09:15 ET Verana Health Introduces Expanded Ovarian Cancer Dataset
artificial intelligence to unlock the true potential of real-world data. With exclusive access to the world's largest patient data sources in oncology, ophthalmology, neurology, and urology. Verana Health is powering real-world evidence generation. Clinicians utilize these insights to improve the quality of care
More news about: Verana Health
May 18, 2026, 20:00 ET Innovent Showcased Clinical and Preclinical Results of Next-Generation Autoimmune and Ophthalmology Pipeline at the 2026 ATS and ARVO Conferences
that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that it will present multiple clinical and preclinical data from IBI3002(IL-4Rα/TSLP), IBI3038(IGF-1R/IL-6),
More news about: Innovent Biologics
May 18, 2026, 16:05 ET REGENXBIO to Participate in Upcoming Investor Conferences
Conference Fireside Chat: Wednesday, May 20 at 9:30am ET Location: New York, NYStifel 2026 Virtual Ophthalmology Forum Fireside Chat: Tuesday, May 26 at 9:30am ET Location: VirtualLive webcasts of select events can
More news about: REGENXBIO Inc.
May 18, 2026, 12:30 ET OMNY Health Surpasses 175 Million Patient Milestone; Launches Oncology Product Suite to Solve Complex Real-World Evidence Gaps
breakthroughs and improves patient outcomes. In addition to its new Oncology product suite, OMNY maintains specialized RWD products in Dermatology, Ophthalmology, Gastroenterology, Respiratory, Cardiology, and Neurology therapeutic areas.For more information, visit:
More news about: OMNY Health